Total planned funding: $736,324,703
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $116,530,809 |
Tanzania | $115,602,195 |
Nigeria | $99,950,183 |
Kenya | $84,843,240 |
Mozambique | $57,200,196 |
Uganda | $53,943,112 |
Rwanda | $41,872,421 |
Zimbabwe | $31,502,137 |
Haiti | $25,875,535 |
Côte d'Ivoire | $20,569,436 |
Ethiopia | $18,086,433 |
Democratic Republic of the Congo | $15,562,193 |
Vietnam | $13,849,933 |
Ukraine | $10,570,699 |
Eswatini | $6,166,486 |
South Sudan | $4,145,007 |
South Africa | $3,957,311 |
Malawi | $2,910,000 |
Burundi | $2,353,388 |
Cameroon | $1,877,113 |
Ghana | $1,750,000 |
Angola | $1,267,189 |
Caribbean Region | $1,233,936 |
Lesotho | $1,000,000 |
Indonesia | $900,001 |
Namibia | $800,000 |
Central America Region | $565,750 |
Burma | $550,000 |
Botswana | $500,000 |
Central Asia Region | $250,000 |
Cambodia | $140,000 |
Organizational Types
Private Contractor | $736,324,703 |
Program Areas
Treatment | $570,660,849 |
Care | $59,568,964 |
Prevention | $45,780,622 |
Governance and Systems | $39,404,754 |
Testing | $20,909,514 |
Budget Codes
HTXD: Treatment: ARV Drugs | $428,756,235 |
HTXS: Treatment: Adult Treatment | $130,310,157 |
HBHC: Care: Adult Care and Support | $39,968,267 |
OHSS: Health Systems Strengthening | $31,041,318 |
HVCT: Testing: HIV Testing and Counseling | $20,909,514 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $16,174,452 |
HVOP: Sexual Prevention: Other Sexual Prevention | $13,503,397 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $12,319,904 |
PDTX: Treatment: Pediatric Treatment | $11,594,457 |
HKID: Care: Orphans and Vulnerable Children | $8,189,646 |
HLAB: Laboratory Infrastructure | $7,430,495 |
HVTB: Care: TB/HIV | $5,884,746 |
PDCS: Care: Pediatric Care and Support | $5,526,305 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,374,215 |
HVSI: Strategic Information | $932,941 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $781,000 |
HMBL: Biomedical Prevention: Blood Safety | $474,023 |
HMIN: Biomedical Prevention: Injection Safety | $153,631 |
Top Partner Programs
Chemonics International:
$736,324,703
View countries